TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Agrenius Lungmedicin AB
Closing information (x1000 SEK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
605
|
691
|
1,112 |
| Financial expenses |
0
|
47
|
0 |
| Earnings before taxes |
73
|
62
|
400 |
| EBITDA |
-4
|
108
|
105 |
| Total assets |
3,133
|
3,238
|
3,665 |
| Current assets |
399
|
293
|
343 |
| Current liabilities |
271
|
175
|
312 |
| Equity capital |
2,729
|
2,896
|
3,124 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
87.1%
|
89.4%
|
85.2% |
| Turnover per employee |
605
|
691
|
1,112 |
| Profit as a percentage of turnover |
12.1%
|
9.0%
|
36.0% |
| Return on assets (ROA) |
2.3%
|
3.4%
|
10.9% |
| Current ratio |
147.2%
|
167.4%
|
109.9% |
| Return on equity (ROE) |
2.7%
|
2.1%
|
12.8% |
| Change turnover |
-86
|
-421
|
35 |
| Change turnover % |
-12%
|
-38%
|
3% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.